{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:20:03Z","timestamp":1793665203947,"version":"4.5.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014943","name":"Sarepta Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ymthe.2025.10.041","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:36:47Z","timestamp":1761316607000},"page":"140-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dose- and genotype-dependent cardiac arrhythmia and sudden death in rats following microdystrophin gene therapy"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6904-2300","authenticated-orcid":false,"given":"Caroline","family":"Le Guiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Toumaniantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurine","family":"Buscara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Cedrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cladice Varela","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Lancelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Georger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Lafoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Couzini\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Augereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Jounier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Hivonnait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Creoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Blaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Huchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumeya","family":"Adjali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Daniele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Perret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.10.041_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The Protein Product of the Duchenne Muscular Dystrophy Locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.10.041_bib2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1242\/jcs.02857","article-title":"Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex","volume":"119","author":"Judge","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymthe.2025.10.041_bib3","first-page":"13","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev."},{"key":"10.1016\/j.ymthe.2025.10.041_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117980","article-title":"The prospects and challenges of small molecule drugs in the treatment of Duchenne muscular dystrophy","volume":"297","author":"Peng","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ymthe.2025.10.041_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.23810","article-title":"Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy","volume":"48","author":"Mendell","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.10.041_bib7","first-page":"117","article-title":"Survival in Duchenne muscular dystrophy","volume":"31","author":"Rall","year":"2012","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13023-021-01862-w","article-title":"The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review","volume":"16","author":"Szabo","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2025.10.041_bib10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/jcm10040820","article-title":"Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy","volume":"10","author":"Fortunato","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymthe.2025.10.041_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2021.100877","article-title":"Therapeutic Approaches for Duchenne Muscular Dystrophy: Old and New","volume":"37","author":"Mackenzie","year":"2021","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib12","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.3233\/JND-210682","article-title":"Exon-Skipping in Duchenne Muscular Dystrophy","volume":"8","author":"Takeda","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2025.10.041_bib13","first-page":"43","article-title":"Read-through approach for stop mutations in Duchenne muscular dystrophy. An update","volume":"40","author":"Politano","year":"2021","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib14","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","article-title":"AAV vectors: The Rubik\u2019s cube of human gene therapy","volume":"30","author":"Pupo","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.041_bib15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cells12050785","article-title":"Various AAV Serotypes and Their Applications in Gene Therapy: An Overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.10.041_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0302-253","article-title":"Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy","volume":"8","author":"Harper","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.10.041_bib17","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.041_bib18","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/mt.2008.186","article-title":"Codon and mRNA Sequence Optimization of Microdystrophin Transgenes Improves Expression and Physiological Outcome in Dystrophic mdx Mice Following AAV2\/8 Gene Transfer","volume":"16","author":"Foster","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.041_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16105","article-title":"Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy","volume":"8","author":"Le Guiner","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.10.041_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","article-title":"Development of Novel Micro-dystrophins with Enhanced Functionality","volume":"27","author":"Ramos","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.041_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/hum.2019.255","article-title":"Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the mdx Mouse Model of Duchenne Muscular Dystrophy","volume":"32","author":"Potter","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.041_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.omtm.2023.05.017","article-title":"Evaluation of an AAV9-mini-dystrophin gene therapy candidate in a rat model of Duchenne muscular dystrophy","volume":"30","author":"Le Guiner","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.10.041_bib23","series-title":"26th Annual Meeting of the American Society of Gene & Cell Therapy","article-title":"More than Nine Year Survival of a GRMD Dog after Injection of AAV-Microdystrophin Gene Therapy","author":"Le Guiner","year":"2023"},{"key":"10.1016\/j.ymthe.2025.10.041_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo1815","article-title":"Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy","volume":"15","author":"Birch","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.10.041_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101519","article-title":"Enhanced therapeutic potential of a microdystrophin with an extended C-terminal domain","volume":"33","author":"Foltz","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.10.041_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.950651","article-title":"Drug development progress in duchenne muscular dystrophy","volume":"13","author":"Deng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.20517\/jtgg.2024.79","article-title":"Duchenne muscular dystrophy, one of the most complicated diseases for gene therapy","volume":"9","author":"Braun","year":"2025","journal-title":"J. Transl. Genet. Genom."},{"key":"10.1016\/j.ymthe.2025.10.041_bib28","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.ymthe.2025.04.045","article-title":"Current clinical applications of AAV-mediated gene therapy","volume":"33","author":"Byrne","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.041_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mus.27955","article-title":"Long-term safety and functional outcomes of delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy: A phase 1\/2a nonrandomized trial","volume":"69","author":"Mendell","year":"2024","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.10.041_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/6981","article-title":"Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences","volume":"17","author":"Li","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.52","article-title":"Full-length Dysferlin Transfer by the Hyperactive Sleeping Beauty Transposase Restores Dysferlin-deficient Muscle","volume":"5","author":"Escobar","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.10.041_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101411","article-title":"Systemic delivery of AAV5, AAV8, and AAV9 packaging a C5-12-microdystrophin-FLAG expression cassette in non-human primates","volume":"33","author":"Liu","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.10.041_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110371","article-title":"Characterization of Dystrophin Deficient Rats: A New Model for Duchenne Muscular Dystrophy","volume":"9","author":"Larcher","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.041_bib34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/019262338601400203","article-title":"Age-Related Variations in Renal Structure and Function in Sprague-Dawley Rats","volume":"14","author":"Owen","year":"1986","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1213\/ane.0b013e3181aa5cf6","article-title":"Malignant Hyperthermia and Muscular Dystrophies","volume":"109","author":"Gurnaney","year":"2009","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ymthe.2025.10.041_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12967-021-03191-9","article-title":"TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD","volume":"19","author":"Creism\u00e9as","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.10.041_bib37","first-page":"1041","article-title":"Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice","volume":"26","author":"Vaillend","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.10.041_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230083","article-title":"Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmdmdx rat model","volume":"15","author":"Caudal","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.041_bib39","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.047704","article-title":"Cardiovascular phenotype of the Dmdmdx rat \u2013 a suitable animal model for Duchenne muscular dystrophy","volume":"14","author":"Szab\u00f3","year":"2021","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2025.10.041_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/ilar\/ilu036","article-title":"Evidence Should Trump Intuition by Preferring Inbred Strains to Outbred Stocks in Preclinical Research","volume":"55","author":"Festing","year":"2014","journal-title":"ILAR J."},{"key":"10.1016\/j.ymthe.2025.10.041_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01527","article-title":"Revealing the Complexity in CD8 T Cell Responses to Infection in Inbred C57B\/6 versus Outbred Swiss Mice","volume":"8","author":"Martin","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib42","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/PHM.0000000000001500","article-title":"Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice","volume":"99","author":"Rodriguez-Cruz","year":"2020","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.ymthe.2025.10.041_bib43","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41434-022-00317-6","article-title":"Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMDmdx rat model","volume":"29","author":"Bourdon","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.041_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nmd.2010.03.007","article-title":"Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials","volume":"20","author":"Arechavala-Gomeza","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2025.10.041_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072147","article-title":"Revertant Fibers in the mdx Murine Model of Duchenne Muscular Dystrophy: An Age- and Muscle-Related Reappraisal","volume":"8","author":"Pigozzo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.041_bib46","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/hmg\/ddl083","article-title":"Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy","volume":"15","author":"Kleopa","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.10.041_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150818","article-title":"Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies","volume":"11","author":"Janghra","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.041_bib48","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/FJC.0b013e318207a35f","article-title":"Fibrosis and cardiac arrhythmias","volume":"57","author":"de Jong","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.joa.2013.12.008","article-title":"Cardiac fibrosis as a determinant of ventricular tachyarrhythmias","volume":"30","author":"Morita","year":"2014","journal-title":"J. Arrhythm."},{"key":"10.1016\/j.ymthe.2025.10.041_bib50","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/j.2040-4603.2017.tb00771.x","article-title":"Cardiac Fibrosis and Arrhythmogenesis","volume":"7","author":"Nguyen","year":"2017","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib51","doi-asserted-by":"crossref","first-page":"11343","DOI":"10.1128\/JVI.76.22.11343-11349.2002","article-title":"A Limited Number of Transducible Hepatocytes Restricts a Wide-Range Linear Vector Dose Response in Recombinant Adeno-Associated Virus-Mediated Liver Transduction","volume":"76","author":"Nakai","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JND-221639","article-title":"Meeting Report: 2022 Muscular Dystrophy Association Summit on \u2018Safety and Challenges in Gene Transfer Therapy\u2019","volume":"10","author":"Lek","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2025.10.041_bib53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0955-0674(05)80012-2","article-title":"Dystrophin and the membrane skeleton","volume":"5","author":"Ervasti","year":"1993","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2019.107411","article-title":"How the central domain of dystrophin acts to bridge F-actin to sarcolemmal lipids","volume":"209","author":"Mias-Lucquin","year":"2020","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib55","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archneur.65.9.1196","article-title":"Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy","volume":"65","author":"Sveen","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymthe.2025.10.041_bib56","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1093\/hmg\/ddr398","article-title":"Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex","volume":"20","author":"Lancioni","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.10.041_bib57","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/CIRCRESAHA.116.305017","article-title":"Ion Channel Macromolecular Complexes in Cardiomyocytes: Roles in Sudden Cardiac Death","volume":"116","author":"Abriel","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.10.041_bib58","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/mus.880181007","article-title":"Dystrophin-positive fibers in duchenne dystrophy: Origin and correlation to clinical course","volume":"18","author":"Fanin","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.10.041_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.45","article-title":"100-fold but not 50-fold dystrophin overexpression aggravates electrocardiographic defects in the mdx model of Duchenne muscular dystrophy","volume":"3","author":"Yue","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.10.041_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165869","article-title":"Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy","volume":"9","author":"Hart","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2025.10.041_bib61","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/CIRCRESAHA.116.305372","article-title":"Proteotoxicity and Cardiac Dysfunction","volume":"116","author":"McLendon","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.10.041_bib62","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.109.904557","article-title":"Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated Cardiomyopathies","volume":"121","author":"Predmore","year":"2010","journal-title":"Circulation"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:34:05Z","timestamp":1783020845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625008627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1525001625008627"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.041","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose- and genotype-dependent cardiac arrhythmia and sudden death in rats following microdystrophin gene therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}